Education
About Us
Working with TipRanks
Follow Us
Nanalysis Scientific (NSCIF)
OTHER OTC:NSCIF
Earnings Data
Report Date
Aug 21, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
>-0.01Last Year’s EPS
-0.01Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 28, 2025
|% Change Since: -5.00%
|Next Earnings Date:Aug 21, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted significant improvements in gross margin, positive adjusted EBITDA, and the successful launch of a new product. However, it also noted challenges such as decreased revenue, a net loss, and economic headwinds affecting sales expectations. Although the company shows progress in certain areas, the balance between positive and negative aspects suggests a neutral overall sentiment.Company Guidance
During Nanalysis Scientific's Q1 2025 conference call, several key financial metrics and strategic insights were discussed. The company reported consolidated revenue of CAD 10.6 million, reflecting a 5% decrease from the previous year. However, there was a notable improvement in the gross margin on product sales, which rose to 66% from 47%, driven by higher average selling prices and reduced manufacturing costs. Adjusted EBITDA improved to CAD 180,000 compared to a loss of CAD 104,000 in Q1 2024, mainly due to a 19% rise in product sales margins. Despite a net loss of CAD 1.3 million, there was a CAD 1.2 million improvement over the prior year, attributed to enhanced margins and cost reduction measures. The company has been EBITDA positive for four consecutive quarters, with a positive operating cash flow of CAD 2.7 million, and it expects continued margin improvements and adjusted EBITDA growth. Additionally, Nanalysis negotiated a favorable renewal of its term loan, including a 12-month reduction in principal payments. The company's outlook remains positive, with expectations of recovering lost revenue ground and leveraging new products and innovations.Improved Gross Margin
Gross margin percentage on product sales increased to 66% from 47% in the previous year, due to improvements in average selling prices and cost reductions.
Positive Adjusted EBITDA
Adjusted EBITDA for Q1 2025 was $180,000 compared to a loss of $104,000 in Q1 2024, marking four consecutive quarters of positive adjusted EBITDA.
Launch of Next-Generation Product
Successfully shipped the next generation 60 megahertz technology, offering over twice the performance of the previous generation.
Positive Operating Cash Flow
Generated $2.7 million of positive operating cash flow in Q1 2025.
Renewal of Term Loan
Negotiated the renewal of the term loan with a 12-month reduction in principal payments.
NSCIF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
NSCIF Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 28, 2025 | $0.20 | $0.18 | -10.00% |
Apr 24, 2025 | $0.23 | $0.24 | +4.35% |
Nov 21, 2024 | $0.27 | $0.26 | -3.70% |
Aug 28, 2024 | $0.29 | $0.31 | +6.90% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Nanalysis Scientific (NSCIF) report earnings?
Nanalysis Scientific (NSCIF) is schdueled to report earning on Aug 21, 2025, TBA Not Confirmed.
What is Nanalysis Scientific (NSCIF) earnings time?
Nanalysis Scientific (NSCIF) earnings time is at Aug 21, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NSCIF EPS forecast?
NSCIF EPS forecast for the fiscal quarter 2025 (Q2) is >-0.01.